Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen-Reference-Cited by-同舟云学术

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

Published:2022-09 Issue:9 Volume:30 Page:2998-3016
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Taha Zaid,Arulanandam Rozanne,Maznyi Glib,Godbout Elena,Carter-Timofte Madalina E.,Kurmasheva Naziia,Reinert Line S.,Chen Andrew,Crupi Mathieu J.F.,Boulton Stephen,Laroche Geneviève,Phan Alexandra,Rezaei Reza,Alluqmani Nouf,Jirovec Anna,Acal Alexandra,Fekete Emily E.F.,Singaravelu Ragunath,Petryk Julia,Idorn Manja,Potts Kyle G.,Todesco Hayley,John Cini,Mahoney Douglas J.,Ilkow Carolina S.,Giguère Patrick,Alain Tommy,Côté Marceline,Paludan Søren R.,Olagnier David,Bell John C.,Azad Taha,Diallo Jean-Simon^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

2. Current strategies of antiviral drug discovery for COVID-19;Mei;Front. Mol. Biosci.,2021

3. HIV entry inhibitors and their potential in HIV therapy;Qian;Med. Res. Rev.,2009

4. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity;Dorr;Antimicrob. Agents Chemother.,2005

5. Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach;Shweta;ChemRxiv,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) binding to angiotensin‐converting enzyme 2;Phytotherapy Research;2023-05-11

2. High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior;Current Drug Targets;2023-04

3. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1;Antiviral Research;2023-01

4. Structural and Spectroscopic Properties of Isoconazole and Bifonazole—Experimental and Theoretical Studies;International Journal of Molecular Sciences;2022-12-28

5. Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer;Frontiers in Immunology;2022-11-03